Retroviral retention activates a Syk-dependent HemITAM in human tetherin
- PMID: 25211072
- PMCID: PMC4161388
- DOI: 10.1016/j.chom.2014.08.005
Retroviral retention activates a Syk-dependent HemITAM in human tetherin
Abstract
Tetherin (BST2/CD317) restricts the release of enveloped viral particles from infected cells. Coupled to this virion retention, hominid tetherins induce proinflammatory gene expression via activating NF-κB. We investigated the events initiating this tetherin-induced signaling and show that physical retention of retroviral particles induces the phosphorylation of conserved tyrosine residues in the cytoplasmic tails of tetherin dimers. This phosphorylation induces the recruitment of spleen tyrosine kinase (Syk), which is required for downstream NF-κB activation, indicating that the tetherin cytoplasmic tail resembles the hemi-immunoreceptor tyrosine-based activation motifs (hemITAMs) found in C-type lectin pattern recognition receptors. Retroviral-induced tetherin signaling is coupled to the cortical actin cytoskeleton via the Rac-GAP-containing protein RICH2 (ARHGAP44), and a naturally occurring tetherin polymorphism with reduced RICH2 binding exhibits decreased phosphorylation and NF-κB activation. Thus, upon virion retention, this linkage to the actin cytoskeleton likely triggers tetherin phosphorylation and subsequent signal transduction to induce an antiviral state.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.
Figures








Comment in
-
Tethering viral restriction to signal transduction.Cell Host Microbe. 2014 Sep 10;16(3):267-9. doi: 10.1016/j.chom.2014.08.013. Cell Host Microbe. 2014. PMID: 25211067
Similar articles
-
Tethering viral restriction to signal transduction.Cell Host Microbe. 2014 Sep 10;16(3):267-9. doi: 10.1016/j.chom.2014.08.013. Cell Host Microbe. 2014. PMID: 25211067
-
Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activities.PLoS Pathog. 2012 Sep;8(9):e1002931. doi: 10.1371/journal.ppat.1002931. Epub 2012 Sep 27. PLoS Pathog. 2012. PMID: 23028328 Free PMC article.
-
Cooperation of the Ebola Virus Proteins VP40 and GP1,2 with BST2 To Activate NF-κB Independently of Virus-Like Particle Trapping.J Virol. 2017 Oct 27;91(22):e01308-17. doi: 10.1128/JVI.01308-17. Print 2017 Nov 15. J Virol. 2017. PMID: 28878074 Free PMC article.
-
Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction.Viruses. 2011 May;3(5):520-40. doi: 10.3390/v3050520. Epub 2011 May 6. Viruses. 2011. PMID: 21994744 Free PMC article. Review.
-
Tetherin/BST-2: Restriction Factor or Immunomodulator?Curr HIV Res. 2016;14(3):235-46. doi: 10.2174/1570162x14999160224102752. Curr HIV Res. 2016. PMID: 26957198 Free PMC article. Review.
Cited by
-
Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence.Viruses. 2016 Mar 3;8(3):67. doi: 10.3390/v8030067. Viruses. 2016. PMID: 26950141 Free PMC article. Review.
-
BST2/tetherin inhibition of alphavirus exit.Viruses. 2015 Apr 22;7(4):2147-67. doi: 10.3390/v7042147. Viruses. 2015. PMID: 25912717 Free PMC article.
-
CD317 Activates EGFR by Regulating Its Association with Lipid Rafts.Cancer Res. 2019 May 1;79(9):2220-2231. doi: 10.1158/0008-5472.CAN-18-2603. Epub 2019 Mar 19. Cancer Res. 2019. PMID: 30890618 Free PMC article.
-
Antagonism of BST2/Tetherin, a new restriction factor of respiratory syncytial virus, requires the viral NS1 protein.PLoS Pathog. 2024 Nov 19;20(11):e1012687. doi: 10.1371/journal.ppat.1012687. eCollection 2024 Nov. PLoS Pathog. 2024. PMID: 39561185 Free PMC article.
-
Limiting Respiratory Viral Infection by Targeting Antiviral and Immunological Functions of BST-2/Tetherin: Knowledge and Gaps.Bioessays. 2018 Oct;40(10):e1800086. doi: 10.1002/bies.201800086. Epub 2018 Aug 16. Bioessays. 2018. PMID: 30113067 Free PMC article. Review.
References
-
- Chu D.H., Morita C.T., Weiss A. The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol. Rev. 1998;165:167–180. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous